Infectious Disease
Navigating COVID-19 in Patients with Comorbidities: Respiratory Conditions
Patients with chronic lung disease are at risk for severe complications of COVID-19. As such, there is a need to better understand how to protect this population. This program reviews the impact of COVID-19 in people with lung disease and other respiratory problems, and provides recommendations to optimize care.
DURATION
20 min
PROFESSION
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-06-15
Patients with chronic lung disease are at risk for severe complications of COVID-19. As such, there is a need to better understand how to protect this population. This program reviews the impact of COVID-19 in people with lung disease and other respiratory problems, and provides recommendations to optimize care.
Note: This expert brief was recorded on May 9th, 2023.
This program has received funding from Moderna Biopharm Canada Inc.
Faculty
Alan Kaplan, MD, CCFP(EM), FCFP, CPC(HC)
Robert Hauptman, BMSc, MD, MCFP
Learning objectives
Upon completion of this continuing education video, participants will be better able to:
- Describe the impact of COVID-19 on individuals with lung disease
- Review NACI recommendations for the COVID-19 primary series and COVID-19 vaccine booster doses
- Summarize therapeutic recommendations for patients with COPD and asthma